Drug
Cannabidiol
Cannabidiol: highest development phase Post-Market, developed by Jazz Pharmaceuticals. 2 trial records tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Jazz Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| Cannabidiol Oral Solution NCT07728097 | Post-Market | Lennox-Gastaut Syndrome |
| Cannabidiol NCT07278505 | Phase 1/2 | Early Life Adversity |
Latest
Follow Cannabidiol on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.